| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | molecular adaptor activity | 1.81e-04 | 1356 | 14 | 6 | GO:0060090 | |
| GeneOntologyMolecularFunction | channel activity | 5.30e-03 | 525 | 14 | 3 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 5.33e-03 | 526 | 14 | 3 | GO:0022803 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 5.92e-03 | 167 | 14 | 2 | GO:0031490 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 7.09e-03 | 1160 | 14 | 4 | GO:0030674 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 7.53e-03 | 1180 | 14 | 4 | GO:0022857 | |
| GeneOntologyMolecularFunction | transporter activity | 1.03e-02 | 1289 | 14 | 4 | GO:0005215 | |
| MousePheno | increased IgG2a level | 4.97e-05 | 74 | 14 | 3 | MP:0008500 | |
| MousePheno | increased IgG2 level | 1.19e-04 | 99 | 14 | 3 | MP:0013803 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 2.13e-04 | 35 | 9 | 2 | M47969 | |
| Pathway | REACTOME_REGULATED_NECROSIS | 6.08e-04 | 59 | 9 | 2 | M41803 | |
| Pathway | REACTOME_REGULATED_NECROSIS | 6.08e-04 | 59 | 9 | 2 | MM15169 | |
| Pubmed | 4.49e-05 | 25 | 14 | 2 | 35139355 | ||
| Pubmed | 1.28e-04 | 42 | 14 | 2 | 35705031 | ||
| Pubmed | 3.98e-04 | 370 | 14 | 3 | 15164053 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q26 | 1.93e-03 | 216 | 14 | 2 | chr3q26 | |
| Coexpression | TRAVAGLINI_LUNG_NONCLASSICAL_MONOCYTE_CELL | 1.10e-04 | 180 | 14 | 3 | M41701 | |
| Coexpression | GSE23321_CD8_STEM_CELL_MEMORY_VS_NAIVE_CD8_TCELL_DN | 1.41e-04 | 196 | 14 | 3 | M8441 | |
| Coexpression | GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_UP | 1.45e-04 | 198 | 14 | 3 | M4534 | |
| Coexpression | GSE15767_MED_VS_SCS_MAC_LN_DN | 1.48e-04 | 199 | 14 | 3 | M3585 | |
| Coexpression | GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP | 1.50e-04 | 200 | 14 | 3 | M7911 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP | 1.50e-04 | 200 | 14 | 3 | M6611 | |
| Coexpression | GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_3DY_UP | 1.96e-04 | 219 | 14 | 3 | M41142 | |
| Coexpression | HAY_BONE_MARROW_MONOCYTE | 2.15e-04 | 226 | 14 | 3 | M39201 | |
| ToppCell | facs-Skin-Telogen-3m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-07 | 176 | 14 | 4 | 9c0fb2c6ae84febdf7c3d4e648985f597dcffe7a | |
| ToppCell | facs-Skin-Telogen-3m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-07 | 176 | 14 | 4 | 3d372c1d527fcc118d1e5809f2524fc387682472 | |
| ToppCell | facs-Skin-Telogen-3m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-07 | 176 | 14 | 4 | 7b3f3d9b33770edf294cee0eccaf8a46f9331461 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-05 | 160 | 14 | 3 | 94e4f5fc2156dd8163811c3b8b0781ea9b3f2e06 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_mem-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.84e-05 | 169 | 14 | 3 | e3ec9468141b6456398dca17dd8eeaabd2462710 | |
| ToppCell | facs-Heart-RV-18m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-05 | 172 | 14 | 3 | 2dcc9d67d6ecc35940eabbc8ed528f5f884f6976 | |
| ToppCell | facs-Heart-RV-18m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-05 | 172 | 14 | 3 | 64d2edbd8e2640b76225597883b1a524e6b1dd3b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-05 | 173 | 14 | 3 | 62ba49c1c16760a8c6cde0cc44e068f94386946a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-05 | 174 | 14 | 3 | 1b2a2129c08bac01fc638692313b196759a1e0d7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-05 | 174 | 14 | 3 | 5bde24eb588dc588efc413811379548120ec0c7f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.22e-05 | 180 | 14 | 3 | 65c069585737302a69b9a01476f4eb8b50cb2bfd | |
| ToppCell | Severe-B_memory-3|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.22e-05 | 180 | 14 | 3 | 90b812c5450359b1745b413421b71e291c97086a | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Lymphocytic-B_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-05 | 186 | 14 | 3 | 0018a949f9f5bfc17f823601303f04dfd56c9a38 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-non-classical_monocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.53e-05 | 188 | 14 | 3 | 3e94d105ca96ceb5fdcca39a8050217913bc02da | |
| ToppCell | 390C-Lymphocytic-B_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.61e-05 | 190 | 14 | 3 | f63c9474f23bb72f0bb1fc531342f0da04ed8b3e | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Lymphocytic_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-05 | 190 | 14 | 3 | 0d0921d67707aea608f52cbb35e54a3892eeffad | |
| ToppCell | 390C-Lymphocytic-B_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.61e-05 | 190 | 14 | 3 | 53bf211f0e8a44f5adb89c43b210a1e35120b6a8 | |
| ToppCell | B_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.65e-05 | 191 | 14 | 3 | 72e3191990973440e4f91427208df360f73e4f41 | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-CD16+_Monocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.77e-05 | 194 | 14 | 3 | 1b4a17d58793e8889484fe592dce8ee1e8fe77a9 | |
| ToppCell | healthy_donor-Myeloid-Monocytic-CD16+_Monocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.77e-05 | 194 | 14 | 3 | ecf746ef1c5c4d6d9ca06a6d3e3778670b5700c2 | |
| ToppCell | COVID_vent-Myeloid-Monocytic-CD16+_Monocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.77e-05 | 194 | 14 | 3 | b133d3d198360269cc449a75d34c29be377d91e0 | |
| ToppCell | severe-Lymphocytic-B_cells_1|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.82e-05 | 195 | 14 | 3 | 73e39005a597e13aea571ae6ae5824d1c7448b71 | |
| ToppCell | NS-moderate-d_16-33-Myeloid-Monocyte-derived_Macrophage|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.82e-05 | 195 | 14 | 3 | d87c83d2d421c9291d0a10bc9db850e9fb337667 | |
| ToppCell | (001)_CD16+_Monocyte|World / immune cells in Peripheral Blood (logTPM normalization) | 2.86e-05 | 196 | 14 | 3 | 33843d550cbca03c044d593b1f6972e4d3871f7f | |
| ToppCell | Int-URO-Myeloid-CD16_Mono|Int-URO / Disease, Lineage and Cell Type | 2.86e-05 | 196 | 14 | 3 | 10772fed1471974cb49155df1da46e4016192620 | |
| ToppCell | COVID-19_Moderate-Non-classical_Monocyte|COVID-19_Moderate / disease group, cell group and cell class | 2.86e-05 | 196 | 14 | 3 | 256c557fa11414c9d2cbb1fcff33f482ee1c78ac | |
| ToppCell | URO-Myeloid-CD16_Mono|URO / Disease, Lineage and Cell Type | 2.90e-05 | 197 | 14 | 3 | 0201ba77419487e75edd5ea07ad7e5cbe87757d4 | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-non-classical_monocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.90e-05 | 197 | 14 | 3 | 1a82e0e74fc5fd71c490d98e8813d719b0b81aa6 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.90e-05 | 197 | 14 | 3 | 0f489d26e4013d1b5a90559856ed2de32a0bb772 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-non-classical_monocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.90e-05 | 197 | 14 | 3 | 1463522df1b6358cbe3b5022a3e153878e9c9e43 | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-non-classical_monocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.90e-05 | 197 | 14 | 3 | 46d8c7e9b3aff70bc58894282d0ec9e87d37235f | |
| ToppCell | Healthy-Non-classical_Monocyte|Healthy / disease group, cell group and cell class | 2.95e-05 | 198 | 14 | 3 | 394e5fa8998c46c6f7cd57b53f347d2029c75ae1 | |
| ToppCell | COVID-19_Moderate-Non-classical_Monocyte|World / disease group, cell group and cell class | 2.95e-05 | 198 | 14 | 3 | 8449934e20bb2a34079fb642cae0d4647b9efe51 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-non-classical_monocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.95e-05 | 198 | 14 | 3 | 11b0d021114df73a539b04f76dd7c63f1fdbdf4f | |
| ToppCell | Healthy-Non-classical_Monocyte|World / disease group, cell group and cell class | 2.95e-05 | 198 | 14 | 3 | 4fd27a9fb3758c94ed9f0a726296e92b0625da44 | |
| ToppCell | BAL-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters | 2.99e-05 | 199 | 14 | 3 | c55181bdec8952b54198f0d4c9c5c84265b16572 | |
| ToppCell | Sepsis-Int-URO-Myeloid-CD16+_Monocyte|Int-URO / Disease, condition lineage and cell class | 3.04e-05 | 200 | 14 | 3 | 3f7fcf55d875cad8f99224d8e4f29eea8308fc8c | |
| ToppCell | Sepsis-URO-Myeloid-CD16+_Monocyte|URO / Disease, condition lineage and cell class | 3.04e-05 | 200 | 14 | 3 | 82408dac860899510a1f5849d2b0b1692053fb96 | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.87e-04 | 94 | 14 | 2 | 9d1dfd534871da30bc25a42e36bed9826f6127d8 | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.87e-04 | 94 | 14 | 2 | 858dda192747e71533736247bc9e135f763a8860 | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.87e-04 | 94 | 14 | 2 | 901c4908d27a06c81853a02042cd331549e0e27d | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-12|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.48e-04 | 112 | 14 | 2 | 96038a5240b89f2f6fd26ec5403ce1e23b01b266 | |
| ToppCell | PND01-03-samps-Lymphocyte-B_cell-B_cell_1|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 7.15e-04 | 128 | 14 | 2 | 5d82247ceda55017628720ed8b6c36ff7cec8437 | |
| ToppCell | PND01-03-samps-Lymphocyte|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 7.15e-04 | 128 | 14 | 2 | d3158825a2178244b57ac5ad2676617fd58d8466 | |
| ToppCell | PND01-03-samps-Lymphocyte-B_cell|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 7.15e-04 | 128 | 14 | 2 | 7661402dd7cd533c1bfe8d9247cecd88c1be9a5e | |
| ToppCell | COVID-19-B_cells-B_cells|COVID-19 / group, cell type (main and fine annotations) | 7.37e-04 | 130 | 14 | 2 | 267b06a0db31e2664cf595cd737402da07ab51cd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.06e-04 | 136 | 14 | 2 | 82b1d6d839c0d0c68e0960549f688138479defcc | |
| ToppCell | PND07-28-samps-Lymphocyte-B_cell-B_cell_2|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 8.18e-04 | 137 | 14 | 2 | 2544d1256f11da6e3bad24a871b2253e0ab20d01 | |
| ToppCell | PND07-28-samps-Lymphocyte-B_cell|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 8.18e-04 | 137 | 14 | 2 | 874e2eaa7846a2832f46b77c726d79f220a4a1cd | |
| ToppCell | LPS-IL1RA-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.42e-04 | 139 | 14 | 2 | 505bf5a483fc2ba69377db9850c3b26ab2f416d1 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_activate-7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.42e-04 | 139 | 14 | 2 | 693ca81f5831b63fe6148ac755631e09f67d0ebf | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 9.28e-04 | 146 | 14 | 2 | 5b2608b56204dda9a773988f42ff00a9fa743a39 | |
| ToppCell | PND01-Immune-Immune_Lymphocytic_T/NK|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.53e-04 | 148 | 14 | 2 | b78dac56b333bf901136ccafb0999f345e978f51 | |
| ToppCell | Control-B_intermediate-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 9.53e-04 | 148 | 14 | 2 | 662c057030effc9eb61216e81d3967e6983c244f | |
| ToppCell | COVID-19_Severe-B_cell|World / disease group, cell group and cell class | 9.66e-04 | 149 | 14 | 2 | 9a9fcbf7e8a6811958f3fd2d36315e19ab2b1127 | |
| ToppCell | Lymphoid|World / shred on cell class and cell subclass (v4) | 9.92e-04 | 151 | 14 | 2 | d7577b2416b91a8be0198dea703385f86f816059 | |
| ToppCell | LPS_only-Lymphocytic_NKT-iNKT/MAIT-T-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.92e-04 | 151 | 14 | 2 | 7270b8bbfae659e110bd9d513b602120b25de3dd | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.00e-03 | 152 | 14 | 2 | ed6df77ba04b715e12c2e1591b4a1e894ca49d25 | |
| ToppCell | COVID-19_Severe-B_cell|COVID-19_Severe / disease group, cell group and cell class | 1.02e-03 | 153 | 14 | 2 | 701a7d92ee7b22277c8462742a530347cc6f061a | |
| ToppCell | E16.5-samps-Endothelial-Immature_fetal_endothelial-Matrix_Endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.03e-03 | 154 | 14 | 2 | 928f49839b046b90c2f942458f3e365ddc4e0bc9 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-B_lymphocytic-memory_B_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.04e-03 | 155 | 14 | 2 | d336559092563b0d7776eef873f1d2759aca45f7 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.04e-03 | 155 | 14 | 2 | efe69145910c5e049d0ed30699c26ef963e0a285 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.06e-03 | 156 | 14 | 2 | 33deda19f06172079ef1dd49fd54d66da1e7fb14 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_2|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-03 | 156 | 14 | 2 | 1a0e081284a99c1b345990775015b8a2fa469496 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-CLP|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-03 | 157 | 14 | 2 | d12f343454202da86a06d0369f8ffe5662cd091b | |
| ToppCell | facs-Lung-24m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.07e-03 | 157 | 14 | 2 | fc0c222124f59c94d60335f849554eaa4062f8c7 | |
| ToppCell | facs-Lung-24m-Hematologic-Lymphocytic_NK_ILC|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.07e-03 | 157 | 14 | 2 | 40b08ace1d9ea7951886f5fed76ac57e9175436b | |
| ToppCell | facs-Lung-24m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-natural_killer|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.07e-03 | 157 | 14 | 2 | 34eb1cbdb023d3e23b2e1695c9c327c21ef1c870 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1-41|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.08e-03 | 158 | 14 | 2 | 6d2709b387945c015faa223c20d22b52a4082140 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.10e-03 | 159 | 14 | 2 | 999f30c7273ed77b34537621bcfcc7fc30121138 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-03 | 159 | 14 | 2 | 997963d879e5819683793cddf5e1acff1b81a1b8 | |
| ToppCell | droplet-Liver-LIVER_NPC|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-03 | 159 | 14 | 2 | e4eaa88772835d6b78e1a18a0cec52de51e80339 | |
| ToppCell | facs-Trachea-nan-18m-Myeloid-lymphocyte_of_B_lineage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-03 | 160 | 14 | 2 | 5c9281706009558c8361bfa76169f43ffc0f7947 | |
| ToppCell | Immune_cells-NK_cells|World / Lineage and Cell class | 1.13e-03 | 161 | 14 | 2 | 3ef2e15b06286d94c18b71626aed456f681cc77b | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-03 | 162 | 14 | 2 | 1fda21a303a08aff6f97819cd8766cd18784d8bc | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-03 | 162 | 14 | 2 | 4b490989005bb03d4e7bbea01580f8548eff150f | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-03 | 162 | 14 | 2 | b46158e260bd2f35702cec73e3b035e8e9ec4469 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.14e-03 | 162 | 14 | 2 | 59f6a9005c4f22f084c25ea36f3cacce5144a9ae | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-03 | 162 | 14 | 2 | 08b7f06580d516307516d5475a5dae0fa040f1a4 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-03 | 162 | 14 | 2 | fc313fb2c55957faa8c9ca4023b3fce63527c267 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-03 | 162 | 14 | 2 | e4a09bf1a51710f6c57e6e01edf8b4619459d96d | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-03 | 162 | 14 | 2 | 002fac3c5c3030950f9eb9e887d59902586d8452 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-ABC_aged-B_naive|bone_marrow / Manually curated celltypes from each tissue | 1.14e-03 | 162 | 14 | 2 | 44832055b11a789e320c802aadb345e065defc8f | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-03 | 162 | 14 | 2 | 66069146e2666d13c594bd76247893354a697c5d | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-03 | 163 | 14 | 2 | a0315855c354e830e109d41bd6e3396488aa8de9 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-03 | 163 | 14 | 2 | 5efecdd8a069a822bc9d35b407092925a865e629 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-ABC_aged-B_memory|bone_marrow / Manually curated celltypes from each tissue | 1.15e-03 | 163 | 14 | 2 | 30f5c93c4e170304d701b5231f0d545f404066f7 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-3|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.15e-03 | 163 | 14 | 2 | 0e8d3c98209fc98b86b841d69051cee9e276d837 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-03 | 163 | 14 | 2 | 801163c05f8fdacaebd0cb9b4c92741276bfa3e3 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-03 | 163 | 14 | 2 | 0d94a427f86e62aba12c397c6d7b8cd297f3a0e5 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 1.17e-03 | 164 | 14 | 2 | 362c16ed7fb37bf16601fd5e059d3f3e2ed692b4 | |
| ToppCell | droplet-Heart-nan-3m-Hematologic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-03 | 164 | 14 | 2 | df9fe446c1a43100048e11c01bf009bec3414dcf | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-ABC_aged-B_memory|bone_marrow / Manually curated celltypes from each tissue | 1.17e-03 | 164 | 14 | 2 | 746833f74095c0f25ce76baf1069f1848c231933 | |
| ToppCell | facs-Trachea-18m-Hematologic-lymphocytic-B_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-03 | 164 | 14 | 2 | 4274a4f225cabf61f0fe27d8ea162b4eba612f87 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-plasma_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-03 | 164 | 14 | 2 | b92e7c91910d518627376166c6ea9ed333b3d07e | |
| ToppCell | facs-Trachea-18m-Hematologic-lymphocytic-B_cell-B_cell_of_the_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-03 | 164 | 14 | 2 | d62143450f59097ad4b34603a6257f897a769ead | |
| ToppCell | droplet-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-natural_killer|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-03 | 164 | 14 | 2 | c2cd4e4b88cc1b80a9494f59d31339007ff824c1 | |
| ToppCell | B_cells-ABCs|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.17e-03 | 164 | 14 | 2 | f45013706a917f0f0d69c23f288128f252cd60c7 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-plasma_cell-plasma_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-03 | 164 | 14 | 2 | a1e43c6b3e2553f5604100db6e92bf244b70c36d | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-03 | 164 | 14 | 2 | a59078c8f88e416e940c9b15151ce7de1bbe987e | |
| Drug | Isradipine [75695-93-1]; Up 200; 10.8uM; PC3; HT_HG-U133A | 5.19e-06 | 198 | 14 | 4 | 6347_UP | |
| Drug | p,p'-DDT | 1.37e-05 | 78 | 14 | 3 | CID000003036 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HG-U133A | 1.83e-04 | 186 | 14 | 3 | 1612_UP | |
| Drug | Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; HL60; HT_HG-U133A | 1.95e-04 | 190 | 14 | 3 | 1343_DN | |
| Drug | Norethynodrel [68-23-5]; Down 200; 13.4uM; HL60; HT_HG-U133A | 2.04e-04 | 193 | 14 | 3 | 1860_DN | |
| Drug | Methylhydantoin-5-(D) [55147-68-7]; Down 200; 35uM; MCF7; HT_HG-U133A | 2.04e-04 | 193 | 14 | 3 | 4113_DN | |
| Drug | Progesterone [57-83-0]; Down 200; 12.8uM; PC3; HT_HG-U133A | 2.04e-04 | 193 | 14 | 3 | 6646_DN | |
| Drug | Nadolol [42200-33-9]; Up 200; 13uM; PC3; HT_HG-U133A | 2.07e-04 | 194 | 14 | 3 | 4021_UP | |
| Drug | genistein; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 2.07e-04 | 194 | 14 | 3 | 1073_UP | |
| Drug | S(-)Eticlopride hydrochloride [97612-24-3]; Up 200; 10.6uM; PC3; HT_HG-U133A | 2.10e-04 | 195 | 14 | 3 | 4634_UP | |
| Drug | Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A | 2.10e-04 | 195 | 14 | 3 | 6180_DN | |
| Drug | Trifluridine [70-00-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 2.10e-04 | 195 | 14 | 3 | 3559_DN | |
| Drug | Netilmicin sulfate [56931-57-2]; Down 200; 2.8uM; HL60; HT_HG-U133A | 2.13e-04 | 196 | 14 | 3 | 2963_DN | |
| Drug | Guaifenesin [93-14-1]; Down 200; 20.2uM; HL60; HT_HG-U133A | 2.16e-04 | 197 | 14 | 3 | 2569_DN | |
| Drug | Flecainide acetate [54143-56-5]; Down 200; 8.4uM; HL60; HT_HG-U133A | 2.16e-04 | 197 | 14 | 3 | 2557_DN | |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 2.16e-04 | 197 | 14 | 3 | 5605_UP | |
| Drug | Propidium iodide [25535-16-4]; Up 200; 6uM; HL60; HT_HG-U133A | 2.16e-04 | 197 | 14 | 3 | 2541_UP | |
| Drug | Cephapirin sodium salt [24356-60-3]; Up 200; 9uM; MCF7; HT_HG-U133A | 2.16e-04 | 197 | 14 | 3 | 3471_UP | |
| Drug | Deptropine citrate [2169-75-7]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 2.20e-04 | 198 | 14 | 3 | 5543_DN | |
| Drug | Dropropizine (R,S) [17692-31-8]; Down 200; 17uM; MCF7; HT_HG-U133A | 2.20e-04 | 198 | 14 | 3 | 5531_DN | |
| Drug | Epicatechin-(-) [154-23-4]; Up 200; 13.8uM; PC3; HT_HG-U133A | 2.20e-04 | 198 | 14 | 3 | 4594_UP | |
| Drug | Rilmenidine hemifumarate [54187-04-1]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 2.20e-04 | 198 | 14 | 3 | 5532_DN | |
| Drug | Conessine [546-06-5]; Down 200; 11.2uM; PC3; HT_HG-U133A | 2.20e-04 | 198 | 14 | 3 | 4191_DN | |
| Drug | sodium 4-phenylbutyrate; Down 200; 200uM; SKMEL5; HG-U133A | 2.20e-04 | 198 | 14 | 3 | 502_DN | |
| Drug | Molsidomine [25717-80-0]; Up 200; 16.6uM; PC3; HT_HG-U133A | 2.23e-04 | 199 | 14 | 3 | 6325_UP | |
| Drug | Streptozotocin [18883-66-4]; Down 200; 15uM; PC3; HT_HG-U133A | 2.23e-04 | 199 | 14 | 3 | 5836_DN | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Up 200; 11.4uM; PC3; HT_HG-U133A | 2.23e-04 | 199 | 14 | 3 | 6324_UP | |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 1.06e-04 | 200 | 14 | 3 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | Intellectual Disability | 1.11e-03 | 447 | 14 | 3 | C3714756 | |
| Disease | sleep apnea measurement | 1.35e-03 | 116 | 14 | 2 | EFO_0007817 | |
| Disease | Global developmental delay | 1.77e-03 | 133 | 14 | 2 | C0557874 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 3.75e-03 | 195 | 14 | 2 | DOID:1574 (implicated_via_orthology) | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 3.94e-03 | 200 | 14 | 2 | EFO_0004611, EFO_0020945 | |
| Disease | Seizures | 4.66e-03 | 218 | 14 | 2 | C0036572 | |
| Disease | cholesteryl ester measurement | 6.42e-03 | 257 | 14 | 2 | EFO_0010351 | |
| Disease | autism spectrum disorder, schizophrenia | 1.02e-02 | 327 | 14 | 2 | EFO_0003756, MONDO_0005090 | |
| Disease | diet measurement | 1.22e-02 | 1049 | 14 | 3 | EFO_0008111 | |
| Disease | sleep duration | 1.24e-02 | 362 | 14 | 2 | EFO_0005271 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RIRTRPALWNKKVWC | 236 | Q8NDB2 | |
| LVTKKKRFWCWQRPK | 36 | O60443 | |
| NWKRKEKLPQVTRSW | 236 | O96019 | |
| CLWAQIQKLKKDRWQ | 231 | Q09161 | |
| DYRWQQVPKKAWRKL | 406 | Q8TEB1 | |
| PSNKNNWKIFRECWK | 1396 | Q7LBC6 | |
| CILWNWNKRKKRQVP | 56 | Q8IWV1 | |
| CWRKWKQLSRLQRNM | 71 | Q9UKM7 | |
| RKGCEWKRFLKNNWV | 6 | P43005 | |
| TVLLACWENWRQKKK | 311 | Q8NBJ9 | |
| CWENWRQKKKTLLVA | 316 | Q8NBJ9 | |
| VCKWQLRRGKKWEIA | 41 | Q6UWF3 | |
| VCIDQWKNKIWPEIK | 101 | Q86VR2 | |
| PCWQVKWQLRQLVRK | 76 | P50591 | |
| WRRCQKCVWKFLEKP | 161 | Q9H3M0 |